Mettler-Toledo International Inc. — 2010 Form 10-K
Reporting period: Fiscal year ended December 31, 2010. This is an annual filing, not a standalone fourth-quarter report; quarterly Q4 figures are included below. Unless otherwise noted, amounts are U.S. dollars.
Business context
Mettler-Toledo supplies precision weighing, laboratory, industrial, food-retail, product-inspection and process-analytics instruments, plus related services. Sales are diversified across geographies, products and customers; no customer represented more than 2% of annual sales. The company reported five operating segments: U.S., Swiss, Western European, Chinese and Other Operations.
Financial performance and liquidity
| Metric | FY 2010 | FY 2009 | Change or context |
|---|---|---|---|
| Net sales | $1,968.2 million | $1,728.9 million | Up 14% in U.S. dollars and local currencies |
| Gross profit / gross margin | $1,037.2 million / 52.7% | $889.3 million / 51.4% | Margin improved 1.3 percentage points |
| Earnings before taxes | $307.5 million | $224.8 million | Up 37% |
| Net earnings | $232.1 million | $172.6 million | Up 35% |
| Diluted EPS | $6.80 | $5.03 | Up 35% |
| Cash from operating activities | $268.3 million | $232.6 million | Higher earnings partly offset by increased working capital |
| Capital expenditures | $73.9 million | $60.0 million | Includes $30.6 million for Blue Ocean |
| Cash and cash equivalents | $447.6 million | $85.0 million | Increase included cash accumulated in the U.S. in connection with foreign-earnings repatriation financing |
| Total debt | $681.2 million | $293.6 million | Net debt after cash was approximately $233.6 million |
| Working capital | $166.0 million | $156.4 million | Company-defined measure, excluding cash and specified debt items |
FY 2010 product sales rose 17% in U.S. dollars; service revenue, including spare parts, rose 5%. Product gross margin increased to 56.5% from 55.2%, while service gross margin edged down to 39.5% from 39.8%. SG&A increased 17% to $588.7 million, reflecting higher performance-related compensation, sales and marketing activity and acquisition expenses. R&D was $97.0 million, or 4.9% of sales.
Fourth-quarter 2010 sales were $592.8 million versus $511.7 million in Q4 2009; net earnings were $80.9 million versus $69.4 million, and diluted EPS was $2.41 versus $2.01.
Operating cash flow exceeded investing outflows of $77.0 million; investing included $73.9 million of capital expenditures and $13.1 million of acquisitions, partly offset by $9.8 million of divestiture proceeds. Financing activities provided $167.9 million, including net borrowing proceeds, and included $240.0 million of share repurchases. The $950 million revolving credit facility had $556.5 million outstanding and approximately $387.9 million available at year-end; the company reported compliance with debt covenants.
Material changes versus 2009
- Sales recovered broadly with improved economic conditions and deferred replacement demand; 2009 sales had fallen 12% in U.S. dollars.
- Chinese Operations were the fastest-growing reported segment: external-customer sales rose 28% to $298.6 million and segment profit rose 34% to $93.0 million. All five segments reported higher segment profit in 2010.
- Gross margin improved with increased volume, operating efficiencies and pricing, partly offset by unfavorable mix, higher materials costs and currency effects.
- Restructuring charges fell to $4.9 million from $31.4 million as the global cost-reduction program, which reduced the workforce by about 1,000, was substantially completed.
- Debt rose substantially, primarily reflecting increased credit-facility borrowing associated with the repatriation-related financing transaction and repayment of the remaining $75 million 4.85% senior notes at maturity.
Outlook, commentary and risks
Management expected sales to increase in 2011 absent a deterioration in global economic conditions, while anticipating slower emerging-market local-currency growth than in 2010 because of the prior-year comparison. No specific 2011 earnings or EPS guidance is provided in the supplied filing text. Management highlighted growth initiatives in market-share gains, emerging markets, product innovation, cost efficiency and strategic acquisitions.
- Blue Ocean: The multi-year global ERP and process-standardization program began its initial rollout in 2010. Expected incremental capitalized project costs were approximately $20 million annually for the next five years; implementation delays, cost overruns or system disruption could impair operations or expected savings.
- Currency exposure: Management estimated that a 1% strengthening of the Swiss franc against the euro could reduce annual pretax earnings by $1.1 million to $1.8 million. Currency changes also affect reported debt.
- Economic and competitive risks: Customer capital spending, particularly in developed markets and the pharmaceutical, food, retail and chemical sectors, may weaken. Competitive pricing and lower-cost emerging-market competitors could pressure margins.
- Debt and liquidity: Debt agreements impose financial-ratio and other covenants; access to the revolving facility depends on lender capacity. Management believed available cash flows and credit facilities would fund anticipated needs for the foreseeable future.
- Environmental contingency: The company estimated about $0.6 million of compliance costs over six years for a New Jersey contamination site. NJDEP had informally indicated a natural-resource-damages claim might be expected, but no claim had been made. Other future environmental liabilities are possible.
- Other exposures: Risks include tax audits and changes in tax rates, pension assumptions and funding needs, supply or system interruptions, product-development execution and potential goodwill or intangible-asset impairment. The company reported no current legal proceeding it believed would materially harm its financial condition, results or cash flows.
Unusual items included a $4.4 million pretax ($3.8 million after-tax) loss on the sale of the retail software business, partly offset by a $1.2 million benefit from contingent consideration. The business’s annualized sales and earnings were described as immaterial. A $5.2 million net discrete tax benefit primarily reflected favorable resolution of prior-year tax matters. The annual effective tax rate was 25%, compared with 23% in 2009.
Important facts for investors to verify
- Reconcile reported debt, cash and the repatriation-related financing transaction, including the location and practical availability of cash held in foreign subsidiaries.
- Track whether revenue growth, gross-margin improvement and strong Chinese segment performance continued after 2010, and how much growth came from acquisitions versus underlying operations.
- Monitor Blue Ocean spending, rollout milestones, operational continuity and evidence of expected cost and working-capital savings.
- Review working-capital trends, especially receivables and inventory, which increased with activity and reported supplier and system-related factors.
- Assess currency sensitivity, pension funding assumptions, tax exposures and developments at the New Jersey environmental site.
- Consider the capital-allocation balance between the remaining $920.6 million share-repurchase authorization, investment needs and debt. The company historically paid no common dividends.
The auditor issued an unqualified opinion on the consolidated financial statements and internal control over financial reporting; management also concluded that internal controls were effective at December 31, 2010.